These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 34758507)
1. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507 [TBL] [Abstract][Full Text] [Related]
2. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229 [TBL] [Abstract][Full Text] [Related]
3. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews. van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338 [TBL] [Abstract][Full Text] [Related]
5. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594 [TBL] [Abstract][Full Text] [Related]
6. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis. Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547 [TBL] [Abstract][Full Text] [Related]
7. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Onland W; van de Loo M; Offringa M; van Kaam A Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887 [TBL] [Abstract][Full Text] [Related]
8. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169 [TBL] [Abstract][Full Text] [Related]
9. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Onland W; De Jaegere AP; Offringa M; van Kaam A Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants. Subramaniam P; Ho JJ; Davis PG Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278 [TBL] [Abstract][Full Text] [Related]
16. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants. Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243 [TBL] [Abstract][Full Text] [Related]
17. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Walker E; Osborn DA Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182 [TBL] [Abstract][Full Text] [Related]